Description

FILITRA PRO 20 MG

Indications

FILITRA PRO 20 MG is primarily indicated for the treatment of erectile dysfunction (ED) in adult men. This condition is characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. FILITRA PRO works by enhancing erectile function in response to sexual stimulation, thereby improving the quality of sexual life for individuals suffering from ED.

Mechanism of Action

The active ingredient in FILITRA PRO is Vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor. The mechanism of action involves the inhibition of the PDE5 enzyme, which is responsible for the breakdown of cyclic guanosine monophosphate (cGMP) in the corpus cavernosum of the penis. During sexual stimulation, nitric oxide (NO) is released, leading to an increase in cGMP levels. By inhibiting PDE5, FILITRA PRO allows cGMP to accumulate, resulting in smooth muscle relaxation and increased blood flow to the penis, facilitating an erection.

Pharmacological Properties

FILITRA PRO exhibits rapid absorption, with peak plasma concentrations occurring approximately 30 to 120 minutes after oral administration. The bioavailability of Vardenafil is approximately 15%, and its effects can last for up to 5 hours, although the duration may vary among individuals. The drug is metabolized primarily in the liver via the cytochrome P450 enzyme system, particularly CYP3A4, and is excreted mainly in the feces and urine.

Contraindications

FILITRA PRO 20 MG is contraindicated in patients who are hypersensitive to Vardenafil or any of the excipients in the formulation. It should not be used in conjunction with nitrates or nitric oxide donors, as this combination can lead to a significant drop in blood pressure. Additionally, it is contraindicated in individuals with severe cardiovascular disorders, including unstable angina or recent history of myocardial infarction, stroke, or life-threatening arrhythmia.

Side Effects

Common side effects associated with FILITRA PRO include headache, flushing, nasal congestion, dyspepsia, and dizziness. These effects are generally mild to moderate and tend to resolve spontaneously. Serious side effects, though rare, may include priapism (prolonged and painful erection), sudden vision loss, or sudden hearing decrease. Patients experiencing any severe or persistent side effects should seek immediate medical attention.

Dosage and Administration

The recommended starting dose of FILITRA PRO is 20 MG, taken orally approximately 30 to 60 minutes before sexual activity. It can be taken with or without food; however, high-fat meals may delay the onset of action. The maximum recommended dosing frequency is once per day. Based on individual efficacy and tolerability, the dose may be adjusted to 10 MG or 5 MG. It is essential to follow the prescribing physician’s instructions regarding dosage adjustments.

Interactions

FILITRA PRO may interact with various medications, potentially altering its effectiveness or increasing the risk of side effects. Concomitant use with other PDE5 inhibitors is not recommended. Caution should be exercised when using FILITRA PRO with medications such as alpha-blockers, antihypertensives, or certain antifungal agents (e.g., ketoconazole) and antibiotics (e.g., erythromycin), as these may enhance the hypotensive effects of Vardenafil. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before initiating treatment with FILITRA PRO, a thorough medical history and physical examination should be conducted to rule out underlying cardiovascular conditions. Patients with a history of priapism, anatomical deformities of the penis, or conditions predisposing to priapism should use FILITRA PRO with caution. Additionally, special care should be taken in elderly patients or those with renal or hepatic impairment, as dosage adjustments may be necessary.

Clinical Studies

Clinical studies have demonstrated the efficacy and safety of FILITRA PRO in treating erectile dysfunction. In randomized, double-blind, placebo-controlled trials, patients reported significant improvements in erectile function and overall satisfaction with sexual activity. The studies indicated that FILITRA PRO effectively improved erectile function scores as measured by the International Index of Erectile Function (IIEF) and the Erectile Function Domain (EFD). The results were consistent across various patient populations, including those with diabetes and prostatectomy.

Conclusion

FILITRA PRO 20 MG is a well-established treatment option for erectile dysfunction, offering a safe and effective solution for men experiencing this condition. With its unique mechanism of action as a PDE5 inhibitor, it enhances erectile function in response to sexual stimulation. However, it is crucial for patients to consult with their healthcare providers to ensure appropriate use, considering potential contraindications and interactions with other medications. By adhering to prescribed dosages and precautions, patients can maximize the benefits of FILITRA PRO while minimizing the risk of adverse effects.